{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T16:08:12Z","timestamp":1762445292443,"version":"build-2065373602"},"reference-count":21,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2022,2,10]],"date-time":"2022-02-10T00:00:00Z","timestamp":1644451200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Oncology"],"abstract":"<jats:p>In the following report, we describe 11 patients with various diagnoses and different treatment statuses (newly diagnosed, receiving treatment, or follow-up) of oncological diseases (breast, lymphoma, melanoma, and head and neck cancers). The patients underwent PET-CT for disease staging or follow-up and it was noted that all patients had areas of hypermetabolic uptake in the axillary lymph-nodes of the ipsilateral upper extremity where the Pfizer-BioNTech coronavirus (COVID-19) vaccine was administered. Following further investigations, including an ultrasound (US), biopsies and an examination of medical records, it was concluded that these findings were the result of the vaccination and not a progression of pre-existing disease.<\/jats:p>","DOI":"10.3390\/curroncol29020084","type":"journal-article","created":{"date-parts":[[2022,2,11]],"date-time":"2022-02-11T02:37:46Z","timestamp":1644547066000},"page":"989-1000","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Metabolic Activity Assessment by 18F-Fluorodeoxyglucose Positron Emission Tomography in Patients after COVID-19 Vaccination"],"prefix":"10.3390","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7570-4550","authenticated-orcid":false,"given":"Walid","family":"Shalata","sequence":"first","affiliation":[{"name":"The Legacy Heritage Oncology Center & Dr. Larry Norton Institute, Soroka Medical Center, Ben Gurion University of the Negev, Beer Sheva 84105, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Levin","sequence":"additional","affiliation":[{"name":"Department of Radiology, Soroka Medical Center, Ben Gurion University, Beer Sheva 84105, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janna","family":"Fridman","sequence":"additional","affiliation":[{"name":"The Legacy Heritage Oncology Center & Dr. Larry Norton Institute, Soroka Medical Center, Ben Gurion University of the Negev, Beer Sheva 84105, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victoria","family":"Makarov","sequence":"additional","affiliation":[{"name":"Department of Radiology, Soroka Medical Center, Ben Gurion University, Beer Sheva 84105, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5488-0996","authenticated-orcid":false,"given":"Muhammed","family":"Iraqi","sequence":"additional","affiliation":[{"name":"The Shraga Segal Department of Microbiology, Immunology, and Genetics, Faculty of Health Science, Ben Gurion University of the Negev, Beer Sheva 8410501, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9004-2831","authenticated-orcid":false,"given":"Mitchell","family":"Golosky","sequence":"additional","affiliation":[{"name":"Medical School for International Health, Ben Gurion University of the Negev, Beer Sheva 84105, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keren","family":"Rouvinov","sequence":"additional","affiliation":[{"name":"The Legacy Heritage Oncology Center & Dr. Larry Norton Institute, Soroka Medical Center, Ben Gurion University of the Negev, Beer Sheva 84105, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Waleed","family":"Kian","sequence":"additional","affiliation":[{"name":"The Legacy Heritage Oncology Center & Dr. Larry Norton Institute, Soroka Medical Center, Ben Gurion University of the Negev, Beer Sheva 84105, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Yakobson","sequence":"additional","affiliation":[{"name":"The Legacy Heritage Oncology Center & Dr. Larry Norton Institute, Soroka Medical Center, Ben Gurion University of the Negev, Beer Sheva 84105, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2022,2,10]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"363","DOI":"10.3322\/caac.21565","article-title":"Cancer treatment and survivorship statistics, 2019","volume":"69","author":"Miller","year":"2019","journal-title":"CA Cancer J Clin."},{"key":"ref_2","unstructured":"(2020). Global Cancer Observatory: Cancer Today, International Agency for Research on Cancer. Available online: https:\/\/gco.iarc.fr\/today."},{"key":"ref_3","first-page":"4S","article-title":"Screening for cancer with PET and PET\/CT: Potential and limitations","volume":"48","year":"2007","journal-title":"J. Nucl. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.ejrad.2009.03.051","article-title":"PET\/CT for the staging and follow-up of patients with malignancies","volume":"70","author":"Poeppel","year":"2009","journal-title":"Eur. J. Radiol."},{"key":"ref_5","unstructured":"Tressaud, A., and Haufe, G. (2008). [18F]-labelled PET and PET\/CT compounds in oncology. Fluorine and Health: Molecular Imaging, Biomedical Materials and Pharmaceuticals, Elsevier Science & Technology."},{"key":"ref_6","unstructured":"FDA (2021, January 17). Fact Sheet for Healthcare Providers Administering Vaccine (Vaccination Providers): Emergency Use Authorization (EUA) of the Pfizer-BioNTech COVID-19 Vaccine to Prevent Coronavirus Disease 2019 (COVID-19), Available online: https:\/\/www.fda.gov\/media\/144413\/download."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1001\/jama.2021.0600","article-title":"Allergic Reactions Including Anaphylaxis after Receipt of the First Dose of Pfizer-BioNTech COVID-19 Vaccine","volume":"325","author":"Shimabukuro","year":"2021","journal-title":"JAMA"},{"key":"ref_8","unstructured":"(2021, November 29). FDA Takes Key Action in Fight against COVID-19 By Issuing Emergency Use Authorization for First COVID-19 Vaccine, Available online: https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-takes-key-action-fight-against-covid-19-issuing-emergency-use-authorization-first-covid-19."},{"key":"ref_9","unstructured":"Local Reactions, Systemic Reactions, Adverse Events, and Serious Adverse Events: Pfizer-BioNTech COVID-19 Vaccine (2021, November 05). Centers for Disease Control and Prevention, Centers for Disease Control and Prevention, Available online: www.cdc.gov\/vaccines\/covid-19\/info-by-product\/pfizer\/reactogenicity.html."},{"key":"ref_10","unstructured":"(2021, February 16). Local Reactions, Systemic Reactions, Adverse Events, and Serious Adverse Events: Moderna COVID-19 Vaccine. Published 11 February 2021, Available online: vaccine.www.cdc.gov\/vaccines\/covid-19\/info-by-product\/moderna\/reactogenicity.html."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"975","DOI":"10.2214\/AJR.21.25728","article-title":"COVID-19 Vaccination-Related Uptake on FDG PET\/CT: An Emerging Dilemma and Suggestions for Management","volume":"217","author":"McIntosh","year":"2021","journal-title":"AJR Am. J. Roentgenol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJMoa2035389","article-title":"Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine","volume":"384","author":"Baden","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrd.2017.243","article-title":"mRNA vaccines\u2014A new era in vaccinology","volume":"17","author":"Pardi","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.clinimag.2021.01.016","article-title":"Unilateral axillary Adenopathy in the setting of COVID-19 vaccine","volume":"75","author":"Mehta","year":"2021","journal-title":"Clin. Imaging"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1053\/snuc.2002.127291","article-title":"Positron emission tomography Imaging in nonmalignant thoracic disorders","volume":"32","author":"Alavi","year":"2002","journal-title":"Semin. Nucl. Med."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3348\/kjr.2006.7.1.57","article-title":"False positive and false negative FDG-PET scans in various thoracic diseases","volume":"7","author":"Chang","year":"2006","journal-title":"Korean J. Radiol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"102220","DOI":"10.1016\/j.ctrv.2021.102220","article-title":"Coordination and optimization of FDG PET\/CT and COVID-19 vaccination; Lessons learned in the early stages of mass vaccination","volume":"98","author":"McIntosh","year":"2021","journal-title":"Cancer Treat. Rev."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s40336-021-00430-3","article-title":"PET findings after COVID-19 vaccination: \u201cKeep Calm and Carry On\u201d","volume":"9","author":"Treglia","year":"2021","journal-title":"Clin. Transl. Imaging"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Treglia, G., Cuzzocrea, M., Giovanella, L., Elzi, L., and Muoio, B. (2021). Prevalence and Significance of Hypermetabolic Lymph Nodes Detected by 2-[18F]FDG PET\/CT after COVID-19 Vaccination: A Systematic Review and a Meta-Analysis. Pharmaceuticals, 14.","DOI":"10.3390\/ph14080762"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.2214\/AJR.21.25928","article-title":"Frequency and Characteristics of Nodal and Deltoid FDG and 11C-Choline Uptake on PET Performed After COVID-19 Vaccination","volume":"217","author":"Schroeder","year":"2021","journal-title":"AJR Am. J. Roentgenol."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Landete, E., G\u00f3mez-Fern\u00e1ndez, I., Gonz\u00e1lez-Gasc\u00f3n-Y-Mar\u00edn, I., Dur\u00e1n-Barquero, C., Churruca, J., Infante, M.S., Mu\u00f1oz-Novas, C., Foncillas, M.\u00c1., Mar\u00edn, K., and Ramos-de-Ascanio, V. (2021). Hypermetabolic abdominal and cervical lymph nodes mimicking Hodgkin lymphoma relapse on FDG PET\/CT after adenovirus-vectored COVID-19 vaccine. Hum. Vaccines Immunother., 1\u20134.","DOI":"10.1080\/21645515.2021.2008215"}],"container-title":["Current Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1718-7729\/29\/2\/84\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:18:04Z","timestamp":1760134684000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1718-7729\/29\/2\/84"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,10]]},"references-count":21,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2022,2]]}},"alternative-id":["curroncol29020084"],"URL":"https:\/\/doi.org\/10.3390\/curroncol29020084","relation":{},"ISSN":["1718-7729"],"issn-type":[{"type":"electronic","value":"1718-7729"}],"subject":[],"published":{"date-parts":[[2022,2,10]]}}}